Whoop introduced a specialized blood testing service on Tuesday designed specifically for women’s health, responding to a massive 150% year-over-year surge in female subscribers. This strategic expansion targets the platform’s fastest-growing demographic, which currently demonstrates 30% higher engagement with the Whoop AI feature compared to other user segments.
Dominating the Rapidly Expanding Female Wearable Market
The shift toward gender-specific health metrics marks a pivotal moment for the wearable technology industry. Whoop’s internal data highlights a significant behavioral trend: women are not only joining the platform at record rates but are also utilizing advanced diagnostic tools more frequently. The 150% increase in female users underscores a growing demand for personalized physiological insights that traditional fitness trackers often overlook.
AI Engagement and the Demand for Personalized Insights
Beyond hardware, Whoop’s software ecosystem reflects this demographic shift. Female members engage with the Whoop AI coach 30% more than the average user, seeking deeper context for their recovery, strain, and sleep data. By integrating direct blood testing, Whoop aims to bridge the gap between external biometric tracking and internal chemical biomarkers, providing a comprehensive view of hormonal health and nutritional status.
The Competitive Landscape: Whoop vs. Oura
Whoop is not alone in identifying this market opportunity. The wearable sector increasingly prioritizes the female experience to drive sustained growth. In October 2025, Oura’s Chief Commercial Officer, Dorothy Kilroy, confirmed that women in their twenties represent that company’s most rapidly expanding user base. As industry leaders pivot toward specialized health solutions, the integration of clinical-grade data like blood testing becomes a key differentiator in securing long-term user loyalty.
